A detailed history of Vickerman Investment Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Vickerman Investment Advisors, Inc. holds 11,614 shares of AMGN stock, worth $3.23 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares
11,614
Previous 11,779 1.4%
Holding current value
$3.23 Million
Previous $3.68 Million 1.68%
% of portfolio
1.13%
Previous 1.22%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$309.38 - $337.38 $51,047 - $55,667
-165 Reduced 1.4%
11,614 $3.74 Million
Q2 2024

Aug 09, 2024

SELL
$262.75 - $319.31 $28,377 - $34,485
-108 Reduced 0.91%
11,779 $3.68 Million
Q1 2024

May 09, 2024

SELL
$268.87 - $324.56 $36,028 - $43,491
-134 Reduced 1.11%
11,887 $3.38 Million
Q4 2023

Jan 09, 2024

SELL
$255.7 - $288.46 $126,571 - $142,787
-495 Reduced 3.95%
12,021 $3.46 Million
Q3 2023

Nov 02, 2023

SELL
$218.65 - $271.46 $15,086 - $18,730
-69 Reduced 0.55%
12,516 $3.36 Million
Q2 2023

Jul 31, 2023

BUY
$214.27 - $253.37 $42,425 - $50,167
198 Added 1.6%
12,585 $2.79 Million
Q1 2023

May 04, 2023

BUY
$225.79 - $275.2 $8,580 - $10,457
38 Added 0.31%
12,387 $2.99 Million
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $33,667 - $42,778
147 Added 1.2%
12,349 $3.24 Million
Q3 2022

Nov 08, 2022

BUY
$224.46 - $253.15 $77,438 - $87,336
345 Added 2.91%
12,202 $2.75 Million
Q2 2022

Aug 09, 2022

BUY
$230.71 - $256.74 $158,267 - $176,123
686 Added 6.14%
11,857 $2.89 Million
Q1 2022

May 09, 2022

BUY
$219.27 - $242.57 $211,595 - $234,080
965 Added 9.46%
11,171 $2.64 Million
Q4 2021

Jan 28, 2022

BUY
$198.88 - $227.6 $215,387 - $246,490
1,083 Added 11.87%
10,206 $2.3 Million
Q3 2021

Dec 13, 2021

BUY
$212.27 - $248.7 $1.94 Million - $2.27 Million
9,123 New
9,123 $1.94 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Vickerman Investment Advisors, Inc. Portfolio

Follow Vickerman Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vickerman Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vickerman Investment Advisors, Inc. with notifications on news.